BioSpace News Archive

Career Advice

Counterproductive Career Advice That You Should Ignore

Getting job-hunting and career advice is hard, especially when you get it from those who have worked for decades. Some advice is still helpful today, like making a good impression, but others are considered counter-productive.

July 29, 2021
·
3 min read
·
Lorenzo Soliman
Business

BioSpace Movers & Shakers, July 30, 2021

Biopharma and life science companies strengthen their leadership teams and boards with these Movers & Shakers.

July 29, 2021
·
9 min read
·
Alex Keown
Business

Profiling the Risk-Benefit Analysis of COVID-19 Vaccines for Kids

The United States and other wealthy nations now stand at an important place in their COVID-19 vaccine campaigns. The question largely turns to vaccinating the remainder of the population – namely, those under 12 years.

July 29, 2021
·
5 min read
·
Heather McKenzie
Drug Development

Vaxart Sees Boosting Immunity with Oral Norovirus Vaccine Candidate, Hope for COVID-19

Clinical-stage biotech company Vaxart announced Thursday that a second dose of its oral norovirus vaccine boosted immunity in clinical trial participants who had previously received the vaccine more than a year prior.

July 29, 2021
·
3 min read
·
Brandon May
Job Trends

Acknowledge These Pros & Cons Before You Hire an Independent Contractor

Discover the pros and cons before you hire an independent contractor (IC). These include freelancers, consultants, seasonal workers, and other temporary professionals.

July 29, 2021
·
4 min read
·
Lorenzo Soliman
Drug Development

Annovis Bio’s AD/PD Therapy Reduces Cytotoxic Cascade in Phase IIa Trials

Annovis Bio’s therapy for Alzheimer’s disease is fast-acting and has the potential for Alzheimer’s patients to significantly improve cognition and motor function, according to data presented at the Alzheimer’s Association International Conference® 2021 (AAIC®), held July 26th through 30th.

July 29, 2021
·
3 min read
·
Gail Dutton
Addex and Indivior Extend Research Collaboration on GABAB Positive Allosteric Modulators - Indivior Commits $4 Million of New Funding

Addex Therapeutics Ltd, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced that it has extended its research collaboration agreement with Indivior PLC.

July 29, 2021
·
5 min read
Policy

FDA Accepts Application for Genentech’s Faricimab for the Treatment of Wet Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME)

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration has accepted the company’s Biologics License Application, under Priority Review, for faricimab for the treatment of wet, or neovascular, age-related macular degeneration and diabetic macular edema.

July 29, 2021
·
10 min read
Business

MorphoSys AG Reports Second Quarter and First Half 2021 Results

We regained the momentum in Monjuvi sales as we exited the second quarter and are encouraged to see that momentum continuing into Q3,” said Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys.

July 29, 2021
·
17 min read
Business

Valneva Appoints Peter Buhler as Chief Financial Officer

Valneva SE announced the appointment of Peter Buhler as Chief Financial Officer and Management Board member.

July 29, 2021
·
2 min read